Teams up for development of core pharmaceutical intermediates
Targeting a bigger share in the domestic statin-based drugs market, Dasan has formed a strategic alliance with Medicam Korea to develop core pharmaceutical intermediates, including atorva...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
